No1258: A multicenter, open-label, four-arm, randomized trial, evaluating the safety and tolerability of BRIVARACETAM intravenous infusion and bolus, administered in b.i.d. regimen as an adjunctive antiepileptic treatment in subject from 16 to 70 years su